EvaLuation of ChemoTherapy induced peRIpheral neuropathy by Current perception threshold

EvaLuation of ChemoTherapy induced peRIpheral neuropathy by Current perception threshold - ELCTRIC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012003

Enrollment

Registered

2013-10-18

Start date

2013-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with cancer 2) Patients who are going to be treated or treated by anticancer agents which inducing peripheral neuropathy 3) 20 years old or more 4) Signed informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who are thought to have palsy of brachial nerve 2) Edema on the diseased side 3) patients who needs treatment for increased pressure on the brain or emergency radiation 4) Pregnant, nursing women, women who are willing to be pregnant 5) Patients with diabetes mellitus 6) Determination as contraindication by doctors

Design outcomes

Primary

Measure	Time frame
relation of patients evaluation and current perception threshold	—

Secondary

Measure	Time frame
Relation of CTCAE, patients evaluation and the rate of current perception threshold Relation of CTCAE, patients evaluation and current perception threshold Amount of anticancer agents The site and period of onset of peripheral neuropathy Safety Time to improvement for chemotherapy induced peripheral neuropathy	—

Countries

Japan

Contacts

Public ContactSatoshi TAMARU

Mie University Hospital Medical oncology

tamaru3@clin.medic.mie-u.ac.jp059-232-1111

Outcome results